MENU

ACTU Actuate Therapeutics Inc Forecast, Technical & Fundamental Analysis

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3)... Show more

ACTU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ACTU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACTU is expected to report earnings to rise 75.00% to -34 cents per share on December 02

Actuate Therapeutics Inc ACTU Stock Earnings Reports
Q3'26
Est.
$-0.35
Q2'26
Beat
by $0.13
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.01
Q3'25
Missed
by $0.07
The last earnings report on September 02 showed earnings per share of -20 cents, beating the estimate of -33 cents. With 124.50K shares outstanding, the current market capitalization sits at 25.58M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1751 River Run
Phone
+1 817 887-8455
Employees
12
Web
https://www.actuatetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRSG1.530.09
+6.25%
Tungray Technologies
VRTX515.440.88
+0.17%
Vertex Pharmaceuticals
ESCA19.51-0.20
-1.01%
Escalade
TBBB50.46-0.88
-1.71%
BBB Foods
AZUL6.85-0.21
-2.97%
AZUL SA

ACTU and Stocks

Correlation & Price change

A.I.dvisor tells us that ACTU and AGEN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACTU and AGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACTU
1D Price
Change %
ACTU100%
-6.96%
AGEN - ACTU
27%
Poorly correlated
+0.73%
TBPH - ACTU
27%
Poorly correlated
-0.06%
PDSB - ACTU
27%
Poorly correlated
-6.47%
APGE - ACTU
25%
Poorly correlated
N/A
DNA - ACTU
25%
Poorly correlated
-0.44%
More
Actuate Therapeutics (ACTU) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com